Leerink Partners Raises Acadia Healthcare (NASDAQ:ACHC) Price Target to $33.00

Acadia Healthcare (NASDAQ:ACHC) had its price objective raised by stock analysts at Leerink Partners from $30.00 to $33.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a “market perform” rating on the stock. Leerink Partners’ target price points to a potential upside of 12.36% from the company’s current price.

Several other brokerages also recently issued reports on ACHC. KeyCorp upped their price target on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. TD Cowen lifted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. Finally, UBS Group lifted their target price on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $30.69.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $29.37 on Wednesday. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of -2.36, a PEG ratio of 9.14 and a beta of 0.62. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $35.83. The stock has a fifty day simple moving average of $30.06 and a 200 day simple moving average of $27.29. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same period last year, the company posted $0.83 EPS. The business’s quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts expect that Acadia Healthcare will post 1.55 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Allworth Financial LP bought a new stake in Acadia Healthcare in the 2nd quarter worth approximately $45,000. Global Retirement Partners LLC purchased a new position in shares of Acadia Healthcare during the second quarter worth approximately $68,000. Integrated Wealth Concepts LLC bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $79,000. Quantbot Technologies LP bought a new position in shares of Acadia Healthcare during the 2nd quarter valued at $88,000. Finally, Public Employees Retirement System of Ohio purchased a new position in Acadia Healthcare in the 2nd quarter worth $144,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.